Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
Titel:
Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
Auteur:
Söderberg, Linda Johannesson, Malin Nygren, Patrik Laudon, Hanna Eriksson, Fredrik Osswald, Gunilla Möller, Christer Lannfelt, Lars